FDAnews
www.fdanews.com/articles/132621-fda-turns-to-advisory-panel-for-comment-on-ect-class

FDA Turns to Advisory Panel for Comment on ECT Class

December 10, 2010
The FDA is asking an advisory committee to weigh in on whether electroconvulsive therapy (ECT) devices should be downgraded to Class II. The Neurological Devices Panel will meet Jan. 27 and 28 to discuss the reclassification of the Class III pre-amendment devices. The FDA also is opening a docket for public comment, which is due Jan. 25.
Devices & Diagnostics Letter